China Biotech Services Holdings (SEHK:8037) Balance Sheet Analysis 2005-2025

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Metric	2024	LTM	2025
Total Cash And Short-Term Investments	HK$18.913M	HK$11.29M	HK$12.083M
Net Receivables	HK$21.045M	HK$7.988M	HK$12.795M
Inventory	HK$3.971M	HK$2.55M	HK$36.939M
Prepaid Expenses And Other Current Assets	HK$4.357M	-	HK$10.751M
Other Current Assets	HK$14.809M	HK$14M	HK$7.121M
Total Current Assets	HK$63.095M	HK$35.828M	HK$79.689M
Property, Plant And Equipment	HK$235.337M	HK$265.098M	HK$401.944M
Goodwill And Intangible Assets	HK$138.838M	HK$139.238M	HK$140.602M
Long-Term Investments	HK$43.229M	HK$43.703M	HK$30.66M
Deferred Tax Assets	-	-	-
Other Noncurrent Assets	HK$49.456M	HK$54.559M	HK$49.68M
Total Noncurrent Assets	HK$466.86M	HK$502.598M	HK$622.886M
Other Assets	-	-	-
Total Assets	HK$529.955M	HK$538.426M	HK$702.575M

Metric	2024	LTM	2025
Total Payables	HK$25.871M	HK$8.098M	HK$34.099M
Accrued Expenses	HK$20.353M	-	-
Short-Term Debt	HK$138.693M	HK$139.179M	HK$247.157M
Current Portion Of Lease Obligations	HK$5.711M	HK$4.391M	-
Income Taxes Payable	HK$117K	-	-
Current Deferred Revenue	-	-	HK$2.983M
Other Current Liabilities	HK$20.504M	HK$44.023M	HK$61.519M
Total Current Liabilities	HK$192.614M	HK$195.691M	HK$345.758M
Long-Term Debt	HK$39.842M	HK$59.809M	HK$136.419M
Capital Lease Obligations	HK$7.504M	HK$9.418M	HK$5.662M
Noncurrent Deferred Revenue	-	-	-
Noncurrent Deferred Tax Liabilities	HK$5.043M	-	HK$4.054M
Other Noncurrent Liabilities	HK$46.482M	HK$60.986M	HK$49.275M
Total Noncurrent Liabilities	HK$94.953M	HK$130.849M	HK$201.072M
Other Liabilities	-	-	-
Total Liabilities	HK$287.567M	HK$326.54M	HK$546.83M

Metric	2024	LTM	2025
Treasury Stock	-	-	-
Preferred Stock	-	-	-
Common Stock	HK$97.573M	HK$97.573M	HK$97.573M
Retained Earnings	HK$-534.467M	-	HK$-603.245M
Additional Paid-In Capital	HK$494.182M	-	HK$494.182M
Accumulated Other Comprehensive Income	HK$207.654M	HK$141.358M	HK$184.297M
Other Stockholders' Equity	-	-	HK$18.603M
Total Common Stockholders' Equity	HK$264.942M	HK$238.931M	HK$191.41M
Minority Interest	HK$-22.554M	HK$-27.045M	HK$-35.665M
Total Equity	HK$242.388M	HK$211.886M	HK$155.745M
Total Liabilities And Equity	HK$529.955M	HK$538.426M	HK$702.575M

Metric	2024	LTM	2025
Total Investments	HK$43.229M	HK$43.703M	HK$30.66M
Total Debt	HK$187.832M	HK$213.433M	HK$394.9M
Net Debt	HK$168.919M	HK$202.143M	HK$382.817M

China Biotech Services Holdings Balance Sheet

Balance Sheet Composition